Search Results - "Sato, Toyomi"

Increased Soluble CD155 in the Serum of Cancer Patients by Iguchi-Manaka, Akiko, Okumura, Genki, Kojima, Hiroshi, Cho, Yukiko, Hirochika, Rei, Bando, Hiroko, Sato, Toyomi, Yoshikawa, Hiroyuki, Hara, Hisato, Shibuya, Akira, Shibuya, Kazuko

“…Emerging evidence suggests that DNAM-1 (CD226) play an important role in the recognition of tumor cells and their lysis by cytotoxic T lymphocytes (CTL) and NK…”
Get full text

Impact of pre-brachytherapy magnetic resonance imaging on dose-volume histogram of locally advanced cervical cancer patients treated with radiotherapy including high-dose-rate brachytherapy by Murofushi, Keiko Nemoto, Ishida, Toshiki, Baba, Keiichiro, Kawakita, Kenji, Sasaki, Tsukasa Saida, Okumura, Toshiyuki, Sato, Toyomi, Sakurai, Hideyuki

“…This study investigated the suitability of brachytherapy technique selection based on pre-brachytherapy magnetic resonance imaging (MRI) findings in cervical…”
Get full text

Can MRI Predict Local Control Rate of Uterine Cervical Cancer Immediately after Radiation Therapy? by SAIDA, Tsukasa, TANAKA, Yumiko OISHI, OHARA, Kiyoshi, OKI, Akinori, SATO, Toyomi, YOSHIKAWA, Hiroyuki, MINAMI, Manabu

“…Purpose: To evaluate the utility of measuring the volumes of areas of high signal intensity on T2-weighted magnetic resonance (MR) images immediately after…”
Get full text

High cost of chemotherapy for gynecologic malignancies by Takahashi, Nobutaka, Seki, Toshiyuki, Sasaki, Keita, Machida, Ryunosuke, Ishikawa, Mitsuya, Yunokawa, Mayu, Matsuoka, Ayumu, Kagabu, Masahiro, Yamaguchi, Satoshi, Hiranuma, Kengo, Ohnishi, Junki, Sato, Toyomi

“…The prognosis of gynecological malignancies has improved with the recent advent of molecularly targeted drugs and immune checkpoint inhibitors. However, these…”
Get full text

Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer by Ebina, Yasuhiko, Mikami, Mikio, Nagase, Satoru, Tabata, Tsutomu, Kaneuchi, Masanori, Tashiro, Hironori, Mandai, Masaki, Enomoto, Takayuki, Kobayashi, Yoichi, Katabuchi, Hidetaka, Yaegashi, Nobuo, Udagawa, Yasuhiro, Aoki, Daisuke

“…The Japan Society of Gynecologic Oncology (JSGO) Guidelines 2017 for the Treatment of Uterine Cervical Cancer are for the purpose of providing standard…”
Get full text

Comparison of preoperative diagnostic performance between dual-energy CT, conventional CT, and MRI in endometrial cancer by Yoshida, Miki, Saida, Tsukasa, Mori, Kensaku, Hoshiai, Sodai, Sakai, Masafumi, Amano, Taishi, Shibuki, Saki, Miyata, Mariko, Sato, Toyomi, Nakajima, Takahito

“…To compare the diagnostic performance of virtual monoenergetic imaging (VMI), computed tomography (CT), and magnetic resonance imaging (MRI) in patients with…”
Get full text

Four cases of Mayer–Rokitansky–Küster–Hauser syndrome treated via non‐surgical vaginal reconstruction using uterine cervical dilators by Kawasaki, Akiko, Itagagi, Hiroya, Tsumagari, Ayako, Ijiri, Hiroko, Yoshikawa, Hiroyuki, Sato, Toyomi

“…Vaginal creation is the standard treatment for Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome. Although non‐surgical method is recommended as a first‐line…”
Get full text

High prevalence of intrapelvic parasitic arteries in patients with placenta accreta spectrum: A case-control study using unenhanced magnetic resonance angiography by Mori, Kensaku, Saida, Tsukasa, Hoshiai, Sodai, Shibuya, Yoko, Obata-Yasuoka, Mana, Ishiguro, Toshitaka, Takahashi, Hiroaki, Hamada, Hiromi, Sato, Toyomi, Minami, Manabu

“…To compare the prevalence of enlarged ovarian and intrapelvic parasitic arteries to the gravid uterus between cases of placenta accreta spectrum (PAS) and…”
Get full text

Difference in Physico-Pharmaceutical Properties between Crystalline and Noncrystalline 9, 3"-Diacetylmidecamycin by SATO, TOYOMI, OKADA, AKIRA, SEKIGUCHI, KEIJI, TSUDA, YASUYUKI

“…The noncrystalline solid form 9, 3"-diacetylmidecamycin (MOM), a new macrolide antibiotic obtained by chemical modification of midecamycin, was prepared by…”
Get full text

Conservative surgery for future pregnancy in young women with ovarian cancer by Miyazaki, Y, Nishida, M, Arai, Y, Sato, T, Tsunoda, H, Kubo, T

Get more information

Adjuvant chemotherapy with cyclophosphamide, adriamycin, and CDDP (CAP) for high risk endometrial cancer after complete surgery by Tsunoda, H, Nishida, M, Arisawa, Y, Sato, T, Oki, A, Nishide, K, Ichikawa, Y, Kubo, T

“…One hundred and six patients with endometrial cancer were treated at Tsukuba University Hospital between 1983 and 1992. Sixteen patients who underwent complete…”
Get more information

Four cases of Mayer-Rokitansky-Küster-Hauser syndrome treated via non-surgical vaginal reconstruction using uterine cervical dilators by Kawasaki, Akiko, Itagagi, Hiroya, Tsumagari, Ayako, Ijiri, Hiroko, Yoshikawa, Hiroyuki, Sato, Toyomi

Get full text

Porous biodegradable microspheres for controlled drug delivery. I: Assessment of processing conditions and solvent removal techniques by SATO, T, KANKE, M, SCHROEDER, H. G, DELUCA, P. P

“…Microspheres containing methylene blue and prednisolone acetate were prepared by one of three methods: freeze-drying, evaporation, and…”
Get full text

DNA fragmentation and expression of BCL-2 protein I trophoblasts of the placenta after placental abruption by Saitoh, Masahiro, Sato, Toyomi, Murakami, Satoshi, Okane, Masato, Ku, Takeshi

Get full text

Experimental studies on absorption, distribution and excretion of a new antibiotic, fosfomycin. II. Absorption of oral preparations of fosfomycin calcium salt in dogs (author's transl) by Fujita, M, Tomo, N, Abe, M, Hosoi, K, Sató, T

“…To establish the best usage and dosage of fosfomycin granule and capsules which had been prepared based on our fundamental experiences as described in the…”
Get more information

Experimental studies on absorption, distribution and excretion of fosfomycin. I. Absorption distribution and excretion of fosfomycin calcium salt (author's transl) by Fujita, M, Tomono, N, Abe, M, Hosoi, K, Sato, T

“…In order to develop some oral drug preparations containing calcium salt of fosfomycin ((minus)-cis-1,2-epoxypropylphosphonic acid) which is a new antibiotic,…”
Get more information